| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC POSITIVE ION MODE | Blank_S14.d | Treatment:blank | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | blank_S22.d | Treatment:blank | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | blank_Sr62.d | Treatment:blank | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | SubCu7_DLN_g1_10 | Treatment:GSK | Gsk Exposure Time (h):10 | ng |
| HILIC POSITIVE ION MODE | SubCu7_NLN_g1_10 | Treatment:GSK | Gsk Exposure Time (h):10 | ng |
| HILIC POSITIVE ION MODE | SubCu7_Tum_g1_10 | Treatment:GSK | Gsk Exposure Time (h):10 | ng |
| HILIC POSITIVE ION MODE | SubCu8_DLN_g1_10 | Treatment:GSK | Gsk Exposure Time (h):10 | ng |
| HILIC POSITIVE ION MODE | SubCu8_NLN_g1_10 | Treatment:GSK | Gsk Exposure Time (h):10 | ng |
| HILIC POSITIVE ION MODE | SubCu8_Tum_g1_10 | Treatment:GSK | Gsk Exposure Time (h):10 | ng |
| HILIC POSITIVE ION MODE | BRN_g1 _Intra7_10h | Treatment:GSK | Gsk Exposure Time (h):10.0 | ng |
| HILIC POSITIVE ION MODE | BRN_g1 _Intra8_10h | Treatment:GSK | Gsk Exposure Time (h):10.0 | ng |
| HILIC POSITIVE ION MODE | LLN_g1 _Intra7_10h | Treatment:GSK | Gsk Exposure Time (h):10.0 | ng |
| HILIC POSITIVE ION MODE | LLN_g1 _Intra8_10h | Treatment:GSK | Gsk Exposure Time (h):10.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Intra7_10h | Treatment:GSK | Gsk Exposure Time (h):10.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Intra8_10h | Treatment:GSK | Gsk Exposure Time (h):10.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Subcutaneous7_10h | Treatment:GSK | Gsk Exposure Time (h):10.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Subcutaneous8_10h | Treatment:GSK | Gsk Exposure Time (h):10.0 | ng |
| HILIC POSITIVE ION MODE | BRN_g1 _Intra1_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | BRN_g1 _Intra2_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | BRN_g1 _Intra3_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | LLN_g1 _Intra1_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | LLN_g1 _Intra2_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | LLN_g1 _Intra3_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Intra1_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Intra2_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Intra3_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Subcutaneous1_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Subcutaneous2_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Subcutaneous3_2h | Treatment:GSK | Gsk Exposure Time (h):2.0 | ng |
| HILIC POSITIVE ION MODE | SubCu1_DLN_g1_2h | Treatment:GSK | Gsk Exposure Time (h):2.00 | ng |
| HILIC POSITIVE ION MODE | SubCu1_NLN_g1_2h | Treatment:GSK | Gsk Exposure Time (h):2.00 | ng |
| HILIC POSITIVE ION MODE | SubCu1_Tum_g1_2h | Treatment:GSK | Gsk Exposure Time (h):2.00 | ng |
| HILIC POSITIVE ION MODE | SubCu2_DLN_g1_2h | Treatment:GSK | Gsk Exposure Time (h):2.00 | ng |
| HILIC POSITIVE ION MODE | SubCu2_NLN_g1_2h | Treatment:GSK | Gsk Exposure Time (h):2.00 | ng |
| HILIC POSITIVE ION MODE | SubCu2_Tum_g1_2h | Treatment:GSK | Gsk Exposure Time (h):2.00 | ng |
| HILIC POSITIVE ION MODE | SubCu3_DLN_g1_2h | Treatment:GSK | Gsk Exposure Time (h):2.00 | ng |
| HILIC POSITIVE ION MODE | SubCu3_NLN_g1_2h | Treatment:GSK | Gsk Exposure Time (h):2.00 | ng |
| HILIC POSITIVE ION MODE | SubCu3_Tum_g1_2h | Treatment:GSK | Gsk Exposure Time (h):2.00 | ng |
| HILIC POSITIVE ION MODE | BRN_g1 _Intra4_6h | Treatment:GSK | Gsk Exposure Time (h):6.0 | ng |
| HILIC POSITIVE ION MODE | BRN_g1 _Intra5_6h | Treatment:GSK | Gsk Exposure Time (h):6.0 | ng |
| HILIC POSITIVE ION MODE | LLN_g1 _Intra4_6h | Treatment:GSK | Gsk Exposure Time (h):6.0 | ng |
| HILIC POSITIVE ION MODE | LLN_g1 _Intra6_6h | Treatment:GSK | Gsk Exposure Time (h):6.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Intra4_6h | Treatment:GSK | Gsk Exposure Time (h):6.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Intra5_6h | Treatment:GSK | Gsk Exposure Time (h):6.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Intra6_6h | Treatment:GSK | Gsk Exposure Time (h):6.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Subcutaneous4_6h | Treatment:GSK | Gsk Exposure Time (h):6.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Subcutaneous5_6h | Treatment:GSK | Gsk Exposure Time (h):6.0 | ng |
| HILIC POSITIVE ION MODE | SER_g1 _Subcutaneous6_6h | Treatment:GSK | Gsk Exposure Time (h):6.0 | ng |
| HILIC POSITIVE ION MODE | SubCu4_DLN_g1_6h | Treatment:GSK | Gsk Exposure Time (h):6.00 | ng |
| HILIC POSITIVE ION MODE | SubCu4_NLN_g1_6h | Treatment:GSK | Gsk Exposure Time (h):6.00 | ng |
| HILIC POSITIVE ION MODE | SubCu4_Tum_g1_6h | Treatment:GSK | Gsk Exposure Time (h):6.00 | ng |
| HILIC POSITIVE ION MODE | SubCu5_DLN_g1_6h | Treatment:GSK | Gsk Exposure Time (h):6.00 | ng |
| HILIC POSITIVE ION MODE | SubCu5_NLN_g1_6h | Treatment:GSK | Gsk Exposure Time (h):6.00 | ng |
| HILIC POSITIVE ION MODE | SubCu5_Tum_g1_6h | Treatment:GSK | Gsk Exposure Time (h):6.00 | ng |
| HILIC POSITIVE ION MODE | SubCu6_DLN_g1_6h | Treatment:GSK | Gsk Exposure Time (h):6.00 | ng |
| HILIC POSITIVE ION MODE | SubCu6_NLN_g1_6h | Treatment:GSK | Gsk Exposure Time (h):6.00 | ng |
| HILIC POSITIVE ION MODE | SubCu6_Tum_g1_6h | Treatment:GSK | Gsk Exposure Time (h):6.00 | ng |
| HILIC POSITIVE ION MODE | QcBRN_S45.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QcBRN_Sr111.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QcBRN_Sr65.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QcBRN_Sr91.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QcLLN_L1002.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QCpool g1 D_NLN_subcu_012.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QCpool g1 D_NLN_subcu_028.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QCpool g1 D_NLN_subcu_037.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QCpool g1 D_NLN_subcu_055.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QCpool g1 D_NLN_subcu_081.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QCpool g1 D_NLN_subcu_135.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QCpool g1 SubTum_038.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QCpool g1 SubTum_056.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QCpool g1 SubTum_082.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QCpool g1 SubTum_136.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QcSer_S24.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | QcSer_S44.d | Treatment:QC | Gsk Exposure Time (h):- | ng |
| HILIC POSITIVE ION MODE | BRN_ctrl_g2_Intra10_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | BRN_ctrl_g2_Intra11_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | BRN_ctrl_g2_Intra12_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | BRN_ctrl_g2_Intra13_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | BRN_ctrl_g2_Intra14_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | BRN_ctrl_g2_Intra15_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | BRN_ctrl_g2_Intra16_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | LLN_ctrl_g2_Intra10_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | LLN_ctrl_g2_Intra11_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | LLN_ctrl_g2_Intra12_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | LLN_ctrl_g2_Intra13_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | LLN_ctrl_g2_Intra15_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | LLN_ctrl_g2_Intra16_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | LLN_ctrl_g2 _Intra9_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Intra10_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Intra11_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Intra12_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Intra13_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Intra14_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Intra15_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Intra16_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2 _Intra9_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Subcutaneous10_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Subcutaneous12_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Subcutaneous13_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Subcutaneous14_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Subcutaneous15_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SER_ctrl_g2_Subcutaneous16_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.0 | ng |
| HILIC POSITIVE ION MODE | SubCu10_DLN_ctrl_g2_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu10_NLN_ctrl_g2_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu10_Tum_ctrl_g2_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu11_DLN_ctrl_g2_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu11_NLN_ctrl_g2_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu11_Tum_ctrl_g2_2h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu12_DLN_ctrl_g2_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu12_NLN_ctrl_g2_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu12_Tum_ctrl_g2_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu13_DLN_ctrl_g2_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu13_NLN_ctrl_g2_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu13_Tum_ctrl_g2_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu14_NLN_ctrl_g2_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu14_Tum_ctrl_g2_6h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu15_DLN_ctrl_g2_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu15_NLN_ctrl_g2_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu15_Tum_ctrl_g2_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu16_DLN_ctrl_g2_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu16_NLN_ctrl_g2_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu16_Tum_ctrl_g2_10h | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu9_DLN_ctrl_g2_2h_ | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu9_NLN_ctrl_g2_2h_ | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
| HILIC POSITIVE ION MODE | SubCu9_Tum_ctrl_g2_2h_ | Treatment:Vehicle | Gsk Exposure Time (h):0.00 | ng |
Return to study ST001838 main page
Download data matrix(Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies HILIC POSITIVE ION MODE)
- Metabolomics Workbench
|